|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_on1144933197 |
| 003 |
OCoLC |
| 005 |
20231120010442.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
200316s2020 ne o 001 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d OCLCF
|d YDX
|d UKMGB
|d N$T
|d UKAHL
|d SFB
|d EBLCP
|d OCLCO
|d OCLCQ
|d OCLCO
|d K6U
|d OCL
|d OCLCQ
|d OCLCO
|
| 015 |
|
|
|a GBC031252
|2 bnb
|
| 016 |
7 |
|
|a 019726364
|2 Uk
|
| 019 |
|
|
|a 1144088379
|a 1144898269
|a 1147863938
|a 1175764512
|
| 020 |
|
|
|a 9780444642189
|q (electronic bk.)
|
| 020 |
|
|
|a 0444642188
|q (electronic bk.)
|
| 020 |
|
|
|z 9780444642172
|q (print)
|
| 020 |
|
|
|z 044464217X
|
| 035 |
|
|
|a (OCoLC)1144933197
|z (OCoLC)1144088379
|z (OCoLC)1144898269
|z (OCoLC)1147863938
|z (OCoLC)1175764512
|
| 050 |
|
4 |
|a RC600
|
| 082 |
0 |
4 |
|a 616.978
|2 23
|
| 245 |
0 |
0 |
|a Infections in systemic autoimmune diseases :
|b risk factors and management /
|c edited by Fabiola Atzeni, James B. Galloway, Juan J. Gomez-Reino, Massimo Galli.
|
| 264 |
|
1 |
|a Amsterdam, Netherlands :
|b Elsevier,
|c 2020.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Handbook of Systemic Autoimmune Diseases ;
|v volume 16
|
| 500 |
|
|
|a Includes index.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed March 16, 2020).
|
| 505 |
0 |
|
|a Front Cover -- Infections in Systemic Autoimmune Diseases: Risk Factors and Management -- Handbook of Systemic Autoimmune Diseases -- Infections in Systemic Autoimmune Diseases: Risk Factors and Management -- Copyright -- Dedication -- Contents -- Contributors -- Preface -- 1 -- Bacterial infections in the lungs of patients with systemic autoimmune diseases -- 1. Introduction -- 2. Increased risk of bacterial infections in the lungs of patients with systemic autoimmune diseases
|
| 505 |
8 |
|
|a 3. Pathogenesis of the increased susceptibility to bacterial infections in the lungs of patients with systemic autoimmune diseases -- 3.1 Effects on the immune response to bacteria of a concomitant immunosuppressive therapy -- 4. Clinical presentation, diagnostic approach, and treatment of the bacterial infections of the lungs in patients with systemi ... -- 5. Prevention of bacterial infections of the lungs in patients with systemic autoimmune diseases -- 6. Conclusions -- 7. Take home messages -- References -- 2 -- Invasive fungal diseases in patients with rheumatic diseases -- 1. Introduction
|
| 505 |
8 |
|
|a 2. Ubiquitous mycoses -- 2.1 Pneumocystosis -- 2.2 Cryptococcosis -- 2.3 Candidiasis -- 2.4 Aspergillosis -- 3. Endemic mycoses -- 3.1 Histoplasmosis -- 3.2 Coccidioidomycosis -- 3.3 Paracoccidioidomycosis -- 3.4 Talaromycosis -- 3.5 Blastomycosis -- 3.6 Sporotrichosis -- References -- 3 -- Urinary tract infection and autoimmune diseases -- 1. Introduction -- 2. Definitions and diagnosis -- 3. Epidemiology and risk factors -- 4. Etiology -- 5. Clinical features -- 6. Supplementary tests -- 6.1 Laboratory findings -- 6.2 Imaging techniques -- 7. Management
|
| 505 |
8 |
|
|a 7.1 Management of nonbacterial urinary tract infections -- Bibliography -- 4 -- Viral hepatitis -- 1. Hepatitis A -- 1.1 Virology and pathogenesis -- 1.2 Natural history -- 1.3 Epidemiology and transmission -- 1.4 Diagnostics -- 1.5 Prevention and therapy -- 1.6 Rheumatologic presentations of hepatitis A -- 1.7 Influence of autoimmune conditions and treatments on hepatitis A -- 1.8 Conclusions -- 2. Hepatitis B -- 2.1 HBV virology -- 2.2 Natural history -- 2.3 Epidemiology and transmission route -- 2.4 Diagnostics -- 2.5 Prevention and therapy
|
| 505 |
8 |
|
|a 2.6 Rheumatologic presentations of hepatitis B infection -- 2.7 Influence of autoimmune conditions on hepatitis B -- 2.8 Influence of autoimmune treatments on hepatitis B -- 2.8.1 Impact on immunization -- 2.8.2 Impact on occult or overt HBV infection -- 2.8.3 Biologics -- 2.8.4 Nonbiologic DMARDs -- 2.9 Management -- 2.10 Conclusions -- 3. HDV coinfection -- 4. Hepatitis C -- 4.1 Natural history -- 4.2 Global epidemiology and transmission route -- 4.3 Diagnostics -- 4.4 Prevention and therapy -- 4.5 Rheumatologic presentations of hepatitis C
|
| 650 |
|
0 |
|a Autoimmune diseases.
|
| 650 |
|
0 |
|a Immune system
|x Infections.
|
| 650 |
|
0 |
|a Immunologic diseases.
|
| 650 |
1 |
2 |
|a Immune System Diseases
|0 (DNLM)D007154
|
| 650 |
|
2 |
|a Autoimmune Diseases
|0 (DNLM)D001327
|
| 650 |
|
6 |
|a Maladies auto-immunes.
|0 (CaQQLa)201-0064242
|
| 650 |
|
6 |
|a Syst�eme immunitaire
|0 (CaQQLa)201-0005078
|x Infections.
|0 (CaQQLa)201-0377634
|
| 650 |
|
6 |
|a Maladies immunologiques.
|0 (CaQQLa)201-0007315
|
| 650 |
|
7 |
|a Immunologic diseases
|2 fast
|0 (OCoLC)fst00967977
|
| 650 |
|
7 |
|a Autoimmune diseases
|2 fast
|0 (OCoLC)fst00822663
|
| 700 |
1 |
|
|a Atzeni, Fabiola,
|e editor.
|
| 700 |
1 |
|
|a Galli, Massimo,
|d 1951-
|e editor.
|
| 700 |
1 |
|
|a Gomez Reino, Juan J.,
|e editor.
|
| 700 |
1 |
|
|a Galloway, James B.
|c (Rheumatologist),
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|z 044464217X
|z 9780444642172
|w (OCoLC)1128376445
|
| 830 |
|
0 |
|a Handbook of systemic autoimmune diseases ;
|v v. 16.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/handbooks/15715078/16
|z Texto completo
|
